XML 85 R71.htm IDEA: XBRL DOCUMENT
v3.23.1

Commitments and Contingencies (Details) | 12 Months Ended
--- | ---
Dec. 31, 2022 USD ($)
Commitments and Contingencies [Abstract] |
Development amount | $ 300,000
Purchase and sale agreement description | On February 7, 2023, the Company entered into a share purchase agreement with N. Danenberg Holding (2000) Ltd to sell the Company’s shares or interests in Wize NC Inc, Occuwize Ltd and Wize Pharma Ltd (“Wize Entities”) effective December 31, 2022 in consideration for $10,000.

X
- Definition Purchase and sale agreement description. + References No definition available. + Details
Name: | migi_Purchasesandsaleagreementdescription
Namespace Prefix: | migi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 932 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-10(c)(7)(ii)) -URI https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862 + Details
Name: | us-gaap_DevelopmentCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration